Archived Webinar: Cirrhosis in 2018: New Help for an Old Liver

Assessment of Needs

The IAS–USA offers this state-of-the-art activity on the evolving challenges of managing HCV disease as part of a nationwide continuing medical education (CME) effort for physicians.

Learning Objectives

Upon completion of this webinar, learners will be able to:

• Use current diagnostic techniques to reliably diagnose cirrhosis in patients with chronic liver injury
• Identify the appropriate use of antibiotics in cirrhosis and describe how the gut microbiome may influence the natural history of cirrhosis
• Describe what happens to the liver after successful treatment of hepatitis C or hepatitis B and identify who remains at risk for complications

Who Should Attend

This advanced webinar is designed for clinical decision makers who are actively involved in HCV care and research.

This activity is also relevant for registered nurses, PharmDs, and other health professionals.

Please note: if you already have participated on the live webinar and have received CME credits, you will not receive additional credits from this activity.

Conflicts of Interest

In the interest of maintaining the independence of its CME activities, and in accordance with the policies of the Accreditation Council for Continuing Medical Education (ACCME), the IAS–USA requires all persons with control of content (eg, faculty, IAS–USA Board members, and program staff) to disclose any financial relationships that they or their spouses or partners have had with commercial companies within the past 12 months. Any real or apparent conflicts of interest of those parties are resolved prior to the CME activity being delivered. Individuals who refuse to disclose financial interests may not participate in an IAS–USA CME activity.